Symbol not found

NYSE:NUVB   00:00AM GMT
0.00
0.00 (0.00%)
Earnings Announcements

Nuvation Bio Reports Second Quarter 2022 Financial Results And Provides Business Update

Published: 08/04/2022 21:10 GMT
Nuvation Bio Inc - Ordinary Shares - Class A (NUVB) - Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update.
Financial Position Provides Cash Runway Through 2028.
Cash, Cash Equivalents and Marketable Securities of $703.8 Million As of June 30, 2022.
Qtrly Loss per Share $0.16.
Q2 Earnings per Share View $-0.13 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.